HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Narcolepsy 1

PROM

Also Known As:

NRCLP1; Narcoleptic Syndrome 1

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Nervous System Diseases: 14178
- Sleep Wake Disorders: 3640
  - Dyssomnias: 27
    - Intrinsic Sleep Disorders: 11
      - Disorders of Excessive Somnolence: 2454
        Narcolepsy: 2625
        Narcolepsy 1: 1
Mental Disorders: 24177
- Sleep Wake Disorders: 3640
  - Dyssomnias: 27
    - Intrinsic Sleep Disorders: 11
      - Disorders of Excessive Somnolence: 2454
        Narcolepsy: 2625
        Narcolepsy 1: 1

Related Diseases

1.	Narcolepsy
2.	Cataplexy

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Narcolepsy 1:

1.	Prazosin (Minipress)FDA LinkGeneric 06/19/1989 - "Our results of in vivo pharmacology and in vitro [3H]prazosin binding in canine narcolepsy now clearly implicate the low affinity [3H]prazosin binding site (alpha 1b) in canine narcolepsy: (1) Prazosin, an alpha 1 antagonist with similar affinity for both subtypes, was much more potent in increasing cataplexy than WB4101, a compound with more affinity for the alpha 1a receptor. "
2.	(2- (2',6'- dimethoxy)phenoxyethylamino)methylbenzo- 1,4- dioxaneIBA 06/19/1989 - "Our results of in vivo pharmacology and in vitro [3H]prazosin binding in canine narcolepsy now clearly implicate the low affinity [3H]prazosin binding site (alpha 1b) in canine narcolepsy: (1) Prazosin, an alpha 1 antagonist with similar affinity for both subtypes, was much more potent in increasing cataplexy than WB4101, a compound with more affinity for the alpha 1a receptor. "